Work

miR-9-3p targets IGF2 to regulate the inflammatory response of hypoxic-reoxygenated cardiomyocytes

Year: 2026
Type: article
Abstract: Globally, the incidence of acute myocardial infarction (AMI) is continuously increasing, which seriously affects the safety of patients with high blood sugar and high blood lipids. This study aimed to explore the effect of the miR-9-3p/insulin-like growth factor2 (IGF2) signaling axis on the hypoxia/reoxygenation (H/R) model. 78 non-AMI subjects and 102 patients with AMI were recruited in this study. miR-9-3p expression and IGF2 expression were detected by RT-qPCR. The pro-inflammatory factors and anti-inflammatory factors were detected by ELISA. A dual luciferase assay was used to verify the targeting relationship between miR-9-3p and IGF2. Multivariate logistic regression was used to explore the independent influencing factors of AMI. miR-9-3p level was increased in AMI patients and in the H/R model. However, IGF2 expression was decreased. After transfection with the miR-9-3p inhibitor, cell viability was significantly increased, the secretion levels of pro-inflammatory factors were significantly decreased, and the levels of anti-inflammatory factors were increased in the H/R model. The dual-luciferase reporter gene assay indicated that IGF2 was the target gene of miR-9-3p. H9c2 cells were transfected with the si-IGF2​, and the results showed that cell viability decreased, the secretion levels of pro-inflammatory factors were increased, and the levels of anti-inflammatory factors were reduced. IGF2 partially reversed the effect of miR-9-3p. The expression of miR-9-3p was elevated in AMI patients and the H/R model. However, the IGF2 level was decreased. The miR-9-3p/IGF2 signaling axis may regulate the inflammatory response in AMI. Not applicable.
Language: English
Subfield: Cancer Research
Open Access status: gold
Estimated APC paid: $2,890
OpenAlex ID: W7237360856
FWCI:
Cites:
Cited by:
Related to: